Retatrutide
Triple-agonist research compound targeting GLP-1, GIP, and glucagon receptors.
Background
Retatrutide is a synthetic peptide engineered as a single-molecule agonist at three incretin and glucagon-family receptors. Active research subject in metabolic and energy-expenditure literature.
Research-grade material; each batch is independently verified for identity, purity and safety, with TFA and heavy-metal screening run on every batch.
Certificate of analysis & pricing
Current-batch COA and reseller pricing unlock with catalogue access.
COA hosted on the lab's own site
Related compounds
Weight Loss Support
Tirzepatide
Dual GIP / GLP-1 receptor agonist. Widely studied in metabolic and incretin research.
Weight Loss Support
Semaglutide
GLP-1 receptor agonist with extended half-life. The most-studied incretin analogue in current metabolic research.
Weight Loss Support
AOD-9604
Anti-Obesity Drug